These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38196069)

  • 1. Yes, nitrous oxide addiction undeniably exists!
    Victorri-Vigneau C; Grall Bronnec M
    Addiction; 2024 Apr; 119(4):625-626. PubMed ID: 38196069
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitrous oxide: a unique official French addictovigilance national survey.
    Guerlais M; Aquizerate A; Lionnet A; Daveluy A; Duval M; Gérardin M; Istvan M; Laforgue EJ; Victorri-Vigneau C;
    Front Public Health; 2023; 11():1167746. PubMed ID: 37206871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrous oxide: A difficult case for classification as an addictive substance.
    Brunt TM
    Addiction; 2024 Apr; 119(4):621-622. PubMed ID: 38123187
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitrous oxide: The label 'potentially addictive' may do more harm than good.
    Winstock AR
    Addiction; 2024 Apr; 119(4):623-624. PubMed ID: 38183384
    [No Abstract]   [Full Text] [Related]  

  • 5. Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
    Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J;
    Therapie; 2020; 75(4):343-354. PubMed ID: 32660776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Nitrous oxide: a unique official French addictovigilance national survey.
    Frontiers Production Office
    Front Public Health; 2023; 11():1235720. PubMed ID: 37469693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHEDRE trial protocol - observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population.
    Gérardin M; Couec ML; Grall-Bronnec M; Feuillet F; Wainstein L; Rousselet M; Pinot ML; Perrouin F; Bonnot O; Drouineau MH; Jolliet P; Victorri-Vigneau C
    BMC Psychiatry; 2015 Nov; 15():281. PubMed ID: 26573686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrous oxide: What do we know about its use disorder potential? Results of the French Monitoring Centre for Addiction network survey and literature review.
    Fidalgo M; Prud'homme T; Allio A; Bronnec M; Bulteau S; Jolliet P; Victorri-Vigneau C
    Subst Abus; 2019; 40(1):33-42. PubMed ID: 30913001
    [No Abstract]   [Full Text] [Related]  

  • 9. Does nitrous oxide addiction exist? An evaluation of the evidence for the presence and prevalence of substance use disorder symptoms in recreational nitrous oxide users.
    Back S; Kroon E; Colyer-Patel K; Cousijn J
    Addiction; 2024 Apr; 119(4):609-618. PubMed ID: 37904333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrous oxide abuse in perspective.
    Gillman MA
    Clin Neuropharmacol; 1992 Aug; 15(4):297-306. PubMed ID: 1516075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrous oxide addiction or not, action is needed. A response to commentaries.
    Back S; Kroon E; Colyer-Patel K; Cousijn J
    Addiction; 2024 Apr; 119(4):627-628. PubMed ID: 38404020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    ; Micallef J; Mallaret M; Lapeyre-Mestre M; Daveluy A; Victorri-Vigneau C; Peyrière H; Debruyne D; Deheul S; Bordet R; Chevallier C; Perault-Pochat MC; Le Boisselier R; Libert F; Chaouachi L; Gillet P
    Therapie; 2021; 76(1):53-54. PubMed ID: 32005483
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?
    Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J
    Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.
    Frauger E; Pauly V; Pradel V; Rouby F; Arditti J; Thirion X; Lapeyre Mestre M; Micallef J
    Fundam Clin Pharmacol; 2011 Oct; 25(5):633-41. PubMed ID: 21077937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Incidence of Signs of Neuropathy and Self-Reported Substance Use Disorder for Nitrous Oxide in Patients Intoxicated with Nitrous Oxide.
    Nugteren-Van Lonkhuyzen JJ; van der Ben L; van den Hengel-Koot IS; de Lange DW; van Riel AJHP; Hondebrink L
    Eur Addict Res; 2023; 29(3):202-212. PubMed ID: 37100039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020.
    Diaz L; Eiden C; Jouanjus E; Frauger E; Fouilhé N; Djezzar S; Gibaja V; Boucher A; Le Boisselier R; Libert F; Caous AS; Monzon E; Guerlais M; Daveluy A; Fauconneau B; Peyrière H
    Therapie; 2023; 78(6):647-657. PubMed ID: 36918317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrous oxide, an opioid addictive agent. Review of the evidence.
    Gillman MA
    Am J Med; 1986 Jul; 81(1):97-102. PubMed ID: 3014879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature.
    Garakani A; Jaffe RJ; Savla D; Welch AK; Protin CA; Bryson EO; McDowell DM
    Am J Addict; 2016 Aug; 25(5):358-69. PubMed ID: 27037733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on zolpidem abuse and dependence.
    Victorri-Vigneau C; Gérardin M; Rousselet M; Guerlais M; Grall-Bronnec M; Jolliet P
    J Addict Dis; 2014; 33(1):15-23. PubMed ID: 24467433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)].
    Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP
    Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.